Background-CYP2El, the coding gene for the ethanol inducible cytochrome P4502E1, is polymorphic at the RsaI restriction site in the 5' flanking region. The mutant allele c2 has a higher transcriptional activity than the wild-type gene cl. P4502E1 catalyses the activation of several environmental carcinogens at a rate that is increased, if only moderately, by longterm ethanol intake. Aims-To establish the distribution of CYP2E1 RsaI polymorphism in patients with hepatocellular carcinoma and to evaluate its possible role in the multifactorial pathogenesis of this tumour. Subjects-101 (84 males) patients with hepatocellular carcinoma and 178 (128 males) healthy controls of the same ethnic (white) and Spanish origin. Methods-After extraction of DNA from white blood celis, alleles ci and c2 of CYP2E1 were identified by restriction fragment length polymorphism (RFLP) with endonuclease RsaI.
The ethanol induciblel 2 cytochrome P-450 isozyme CYP2E1 catalyses the oxidation of more than 75 xenobiotic substrates, including ethanol itself, drugs (paracetamol, chlorzoxazone), and several potential carcinogens (some nitrosamines, benzene, aniline)3 4 that are transformed to their ultimate reactive forms.
High ethanol intake is a well known carcinogenic factor for the upper alimentary tract, specially if associated with tobacco use. 5 Primary liver cancer usually complicates several chronic liver diseases, mainly those induced by hepatitis B and C virus.6-8 Although liver cancer is a frequent terminal event in alcoholic cirrhosis, the high incidence of coexistent HCV chronic infection in these patients makes doubtful the role of alcohol itself as a definite risk factor for hepatoma.9 Nevertheless, tobacco use may be related to the incidence of hepatoma in cirrhotic patients, although current data are controversial.9-"1 Theoretically, the induction of CYP2E1 would result in an increase of the rate of activation of carcinogens that reach the liver in subjects who misuse alcohol.'2 Many carcinogens are present in tobacco smoke and indeed in many foods, and the broad spectrum of substrates for CYP2E1 includes many of them.3 4 CYP2E1 gene is polymorphic at several levels. One of these polymorphisms involves Pst I and Rsa I sites in the 5' flanking region; the rare allele c2 is associated with increased gene expression'3 but, up to now, its real effect on the enzymic activity in vivo has not been fully investigated, partly because of its low incidence.'4 15 No relation has been found between this polymorphic trait and the risk of lung cancer.16 17 Nevertheless, the liver is a better candidate for these type of studies because its high rate of specific CYP2E1 activity after alcohol induction'8 and because it must cope with all the CYP2E1 substrates absorbed in the gut, including tobacco specific carcinogens dissolved in swallowed saliva.
Therefore, CYP2E1 may modulate the risk of liver cancer through two different mechanisms that influence its rate of activity. One is genetic and lies upon functional differences between Rsa I polymorphic cl and c2 alleles. The other depends on environmental factors, mainly ethanol or other inducers, which frequently show also a carcinogenic potential in the liver. This study aims to elucidate the role of the Rsa I genetic polymorphism in liver cancer risk in a large series ofpatients with liver cancer and different aetiological profiles.
Methods

Study population
One hundred and one patients (84 males, mean (SD) age 67 (8.5) years) diagnosed with primary liver cancer (hepatocarcinoma) were included in the study. The diagnosis of hepatoma was based upon positive imaging studies (ultrasonography, computed tomography or angiography, or all three) in all patients, and confirmed by fine needle aspirative cytology or histological analysis of the tumour (75 patients) or by an ox fetoprotein concentration of at least 700 ng/ml in absence of other known primary malignancy in the remaining 26 cases.
Seventy seven patients had a previous diagnosis of chronic liver disease: 67 were cirrhotic (by clinical, analytical, and imaging criteria), seven had a definite histological diagnosis of chronic active hepatitis, and there were two other patients with porphyria cutanea tarda without evidence of cirrhosis and one with haemochromatosis. There were no data of previous liver disease in 24 patients, but the histology of the non-tumoral liver was known only in one (normal liver). Viral hepatitis B (VHB) and C (VHC) markers were known in all but two patients. Six were positive for HBsAg, 27 for anti-HBs, 46 for anti-HBc, and 71 for anti-HCV (ELISA second generation or western blot assays, or both). Thirteen patients were negative for all serum VHB and VHC markers. Data on tobacco and alcohol consumption were collected; alcohol use was categorised in two levels: teetotallers or drinkers less than 50 g/day and drinkers of more than 50 g/day. This limit is somewhat lower than that fixed by most authors for the cirrhogenic effect of ethanol,19 20 but it was chosen because it is probably closer to the threshold for the ethanol inducing effect on CYP2E1 activity. 12 The control group was composed of 178 subjects (128 males We have not found any relation between tobacco use, RsaI CYP2E1 genotype, and risk of hepatoma, a possible link detected among 30 hepatoma patients of Taiwanese origin. In that study23 the 13 patients with hepatoma who smoked carried the cl cl genotype. It must be stated that the prevalence of the c2 allele in populations of Oriental origin is much higher than in white people. Thus, the absolute prevalence of the ci allele in this small subgroup reached statistical significance.
There are various possibilities to explain the link between the CYP2E1 c2 allele carrier state and ethanol intake. Cytochrome 2E1 enzyme is inducible by ethanol at comparatively low doses,'2 which increases its rate of activation of specific carcinogens. Aflatoxin, a well known liver carcinogen, does not follow the CYP2Ei route for its activation24; however, it should be kept in mind that aflatoxin B 1 is not a relevant factor in the aetiology of liver cancer in Western countries. More relevant may be the role of N-nitrosodimethylamine (NDMA), an environmental procarcinogen. Human beings are exposed to very low concentrations of NDMA, the same that are metabolised exclusively by CYP2E1 .25 Rats exposed to such low doses of NDMA develop hepatocarcinoma only when they are simultaneously treated with ethanol. 26 The CYP2E1 c2 gene has a higher transcriptional activity than its ci counterpart. 13 Induction of cytochrome P-4502E1 in human liver by ethanol is probably secondary to an increase in encoding mRNA,27 but that study only included five 'induced' patients with unknown genotype and the chance of having selected at least one carrier of one c2 gene is quite low. In fact, the rate of increase of enzymic activity after treatment with ethanol was very similar in these five subjects. If the c2 gene had a higher rate of ethanol inducibility, carriers of one copy of it (homozygote c2c2 are very uncommon) should be exposed to greater doses of activated carcinogens if they were drinkers, even moderate, of ethanol. The increased transcriptional activity of the C2 gene can also cause, even without ethanol related induction, an increased rate of activation of carcinogens. At present, this hypothesis is merely speculative and should be confirmed through studies in humans. Lucas et a128 have reported that patients with the genotype clc2 seem to be less inducible than those with the genotype clcl after ethanol induction. This could be explained if the increases in the enzymic activity caused by the C2 allele increased transcriptional rate and by the ethanol inductive properties were not additive. However, it seems that we still do not have adequate non-toxic substrates to confirm these type of studies, because the only one proposed by Kim et all4 and used in the study by Lucas et al,28 chlorzoxazone, which is transformed in its 6-hydroxy metabolite by CYP2E1 mediated catalysis, does not fulfil the minimum requirements to be used as a reliable probe for these studies29 nor is it specific for CYP2E13l
It could be argued that the c2 gene is related to the risk of alcoholic cirrhosis instead of influencing the subsequent malignant transformation. Nevertheless, ethanol is probably not the main aetiological factor of the liver disease developed by these patients, because only a few were actually heavy drinkers and 25 were anti-HCV reactive. Moreover, we have found that the distribution of this polymorphism in 58 patients with severe chronic alcoholic liver disease (cirrhosis) is very similar to that found in normal controls (unpublished data), confirming the findings made in other white populations.3' 32 In conclusion, we have found an overrepresentation of carriers of the CYP2E1 c2 gene among patients with hepatocarcinoma complicating chronic liver disease and with a history of regular significant ethanol intake. Studies are needed to elucidate the basis of the interaction between this infrequent allele and ethanol, which may increase the risk ofhepatocarcinoma in otherwise predisposed patients.
